Palmitoylethanolamide (PEA) vs NSAIDs: Evaluating a Long-Term Option for Inflammatory Pain
How does PEA compare to ibuprofen and naproxen for inflammatory pain? We examine the mechanisms, clinical evidence, and safety profiles of both.
How does PEA compare to ibuprofen and naproxen for inflammatory pain? We examine the mechanisms, clinical evidence, and safety profiles of both.
Explore how palmitoylethanolamide (PEA) may combine with luteolin, omega-3s, and other supplements—mechanisms, practical considerations, and honest caveats.
Learn how PEA activates the PPAR-α nuclear receptor to reduce inflammation and pain—what the science shows and what it means for supplementation.
PEA is an endogenous fatty acid amide studied for neuroinflammation and pain in multiple sclerosis. Here is what current evidence shows.
Explore how PEA may reduce IBS gut pain through mast cell stabilization and PPAR-α activation. Evidence-based overview with cited research.
What does the research actually say about palmitoylethanolamide drug interactions? An honest, evidence-based look at PEA and medications.
Living with chronic pain, be it the widespread ache of fibromyalgia, the debilitating grip of endometriosis, or the burning sting
An evidence-based review of PEA for chronic low back pain, covering proposed mechanisms, clinical trial results, formulation differences, and honest caveats.
PEA and curcumin both target inflammation by different mechanisms. An honest comparison of how each works, their limitations, and who might benefit from either.
Micronized and ultramicronized PEA differ meaningfully in particle size and dissolution rate. Here is what the research evidence actually shows about each form.
A condition-specific guide to choosing a PEA supplement for fibromyalgia — covering formulation, dose, quality markers, and honest evidence limits.